Ming Du

Ming Du

Auto-generated profile, based on publicly available information

Ming Du

Department of Biochemistry & Molecular Genetics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
GGGwen Gunn
Gwen Gunn
YDYanying Dai
Yanying Dai
MDMing Du
Ming Du
VBValery Belakhov
Valery Belakhov
JKJeyakumar Kandasamy
Jeyakumar Kandasamy
KKKim Keeling
Kim Keeling

Verified
Journal Article
Open access
PDF file
ASAmna Siddiqui
Amna Siddiqui
HDHALIL DUNDAR
HALIL DUNDAR
JSJyoti Sharma
Jyoti Sharma
AKAneta Kaczmarczyk
Aneta Kaczmarczyk
JEJosh Echols
Josh Echols
KKKim Keeling
Kim Keeling
Mucopolysaccharidosis I-Hurler (MPS I-H) is caused by the loss of α-L-iduronidase, a lysosomal enzyme that degrades glycosaminoglycans. Current therapies cannot treat many MPS I-H manifestations. In this study, triamterene, an FDA-approved, antihypertensive diuretic, was found to suppress translation termination at a nonsense mutation associated with MPS I-H. Triamterene rescued enough α-L-iduronidase function to normalize glycosaminoglycan storage in cell and animal models. This new function of triamterene operates through premature termination codon (PTC) dependent mechanisms that are unaffected by epithelial sodium channel activity, the target of triamterene’s diuretic function. Triamterene represents a potential non-invasive treatment for MPS I-H patients carrying a PTC.